GlassScriptPhysician profile
Akshay D Patel
NPI 1396737581
$27,453.75
in general payments reported to CMS, 2019-2025
16 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $6,996 · 2021: $42.05 · 2022: $40.37 · 2023: $338 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $26,688.28 | 2019-2020 | |
| Exact Sciences Corporation | $138.95 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2023 | Tezspire |
| Davol INC. | $120.77 | 2023 | Arista Ah Flexitip |
| Boston Scientific Corporation | $82.55 | 2020 | |
| Nestle Healthcare Nutrition INC. | $68.93 | 2021-2022 | |
| Novo Nordisk INC | $43.43 | 2019-2023 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $41.49 | 2019 | |
| Lilly USA, LLC | $30.37 | 2025 | Jardiance, Kisunla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.57 | 2025 | Caplyta |
| Lundbeck LLC | $18.42 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $18.02 | 2025 | Capvaxive, Gardasil 9 |
| Vanda Pharmaceuticals INC. | $16.56 | 2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $15.31 | 2025 | Rexulti |
| Allergan, INC. | $13.61 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.